DESFERAL Side Effects

6980513-9 | Bedridden, Haemosiderosis, Hepatic Cirrhosis, Osteoporosis, Sedation, Spinal Fracture
on Sep 02, 2010 Male patient from BELGIUM , 48 years of age, was diagnosed with haemosiderosis and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: bedridden, haemosiderosis, hepatic cirrhosis, osteoporosis (What is osteoporosis?), sedation, spinal fracture. Desferal dosage: . During the same period patient was treated with GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), NSAID'S (View Nsaid's Review and Nsaid's Label ), DEANXIT (View Deanxit Review and Deanxit Label ), INDERAL (80) (View Inderal Review and Inderal Label ).

6862321-2 | Metallosis Of Globe, Retinal Disorder, Retinogram Abnormal, Visual Acuity Reduced
Patient was taking Desferal (View Usage). Patient had the following side effects: metallosis of globe, retinal disorder (What is retinal disorder?), retinogram abnormal, visual acuity reduced on Jul 08, 2010 from JAPAN Additional patient health information: Male patient , 59 years of age, was diagnosed with corneal opacity, heterochromia iridis and. Desferal dosage: .

6840230-2 | Eye Disorder, Retinal Dystrophy
Adverse event was reported on Jun 30, 2010 by a Male patient taking Desferal (View Usage) (Dosage: 4 Units Per Week) was diagnosed with thalassaemia beta, vitamin supplementation and. Location: UNITED KINGDOM , weighting 48.72 lb, After Desferal was administered, patient had the following side effects: eye disorder, retinal dystrophy. During the same period patient was treated with VITAMIN C (Unk) (View Vitamin C Review and Vitamin C Label ), ABDEC (0.6 Ml, Qd) (View Abdec Review and Abdec Label ), SOLVAZINC (1 Df, Qd) (View Solvazinc Review and Solvazinc Label ).

6800903-4 | Pain
on Jun 16, 2010 Female patient from GREECE , 43 years of age, was diagnosed with thalassaemia and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: pain (What is pain?). Desferal dosage: .


6789798-5 | Osteoporosis, Spinal Fracture
on Jun 09, 2010 Male patient from BELGIUM , 48 years of age, was diagnosed with haemosiderosis and was treated with Desferal (View Usage). Patient had the following side effects: osteoporosis (What is osteoporosis?), spinal fracture. Desferal dosage: . During the same period patient was treated with GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), NSAID'S (View Nsaid's Review and Nsaid's Label ), DEANXIT (View Deanxit Review and Deanxit Label ), INDERAL (80) (View Inderal Review and Inderal Label ).

6783560-5 | Abortion Spontaneous, Haemoglobin Decreased, Hypoxia
Patient was taking Desferal (View Usage). After Desferal was administered, patient had the following side effects: abortion spontaneous, haemoglobin decreased, hypoxia on Jun 10, 2010 from IRAN (ISLAMIC REPUBLIC OF) Additional patient health information: Female patient , 29 years of age, . Desferal dosage: .

6767842-9 | Abdominal Abscess, Abdominal Mass, Abdominal Operation, Abdominal Pain, Klebsiella Infection, Pyrexia
Adverse event was reported on Jun 09, 2010 by a Female patient taking Desferal (View Usage) (Dosage: Unk) was diagnosed with iron overload, diabetes mellitus and. Location: TURKEY , weighting 119.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal abscess, abdominal mass, abdominal operation, abdominal pain (What is abdominal pain?), klebsiella infection, pyrexia. During the same period patient was treated with INSULIN (Unk) (View Insulin Review and Insulin Label ), FOLBIOL (View Folbiol Review and Folbiol Label ), CALCIUM SANDOZ (View Calcium Sandoz Review and Calcium Sandoz Label ). Patient was hospitalized.

6693878-2 | Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, Blood Potassium Increased, Blood Urea Increased, C-reactive Protein Increased, Cardiac Failure, Cellulitis, Depressed Level Of Consciousness, Disseminated Intravascular Coagulation
on Apr 16, 2010 Male patient from JAPAN , weighting 97.00 lb, was diagnosed with myelodysplastic syndrome and was treated with Desferal (View Usage). Patient had the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, c-reactive protein increased, cardiac failure, cellulitis (What is cellulitis?), depressed level of consciousness, disseminated intravascular coagulation. Desferal dosage: 500-1000 Mg/3 Times A Week. During the same period patient was treated with PRIMOBOLAN (View Primobolan Review and Primobolan Label ).

6680743-X | Blood Potassium Increased, C-reactive Protein Increased, Haematocrit Decreased, Haemoglobin Decreased, Hypotension, Lung Infiltration, Mucormycosis, Platelet Count Decreased, Pyrexia
on Mar 31, 2010 Male patient from JAPAN , weighting 97.00 lb, was diagnosed with myelodysplastic syndrome and was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: blood potassium increased, c-reactive protein increased, haematocrit decreased, haemoglobin decreased, hypotension, lung infiltration, mucormycosis, platelet count decreased, pyrexia. Desferal dosage: 500-1000 Mg/3 Times A Week. During the same period patient was treated with PRIMOBOLAN (View Primobolan Review and Primobolan Label ).

6574727-X | Eye Disorder, Retinal Dystrophy
Patient was taking Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: eye disorder, retinal dystrophy on Jan 27, 2010 from UNITED KINGDOM Additional patient health information: Male patient , child 8 years of age, . Desferal dosage: Unk.

6502969-8 | Cardiac Failure
Adverse event was reported on Dec 13, 2009 by a Male patient taking Desferal (View Usage) (Dosage: 125mg/kg) was diagnosed with iron overload and. Location: ISRAEL , 26 years of age, Patient had the following side effects: cardiac failure. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CALCIUM (View Calcium Review and Calcium Label ), TESTOSTERONE ENANTHATE (View Testosterone Enanthate Review and Testosterone Enanthate Label ). Patient was hospitalized.

6500395-9 | Bronchospasm, Pallor, Pruritus, Rash
on Dec 05, 2009 Female patient from INDIA , 25 years of age, was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: bronchospasm, pallor, pruritus, rash (What is rash?). Desferal dosage: 10 Vials. During the same period patient was treated with VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ).

6426427-4 | Subcutaneous Haematoma, Thrombocytopenia
on Oct 21, 2009 Male patient from FRANCE , 82 years of age, was diagnosed with refractory anaemia and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: subcutaneous haematoma, thrombocytopenia. Desferal dosage: Unk. During the same period patient was treated with MOTILIUM (View Motilium Review and Motilium Label ), CIPRALAN (View Cipralan Review and Cipralan Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ).

6409115-X | Chorioretinal Atrophy, Optic Neuritis, Optic Neuropathy, Scotoma, Visual Acuity Reduced
Patient was taking Desferal (View Usage). Patient had the following side effects: chorioretinal atrophy, optic neuritis, optic neuropathy, scotoma, visual acuity reduced on Oct 06, 2009 from FRANCE Additional patient health information: Male patient , 60 years of age, was diagnosed with myelodysplastic syndrome, iron overload and. Desferal dosage: Unk.

6389184-6 | Cardiac Discomfort, Dyspnoea, Incorrect Dose Administered, Pulmonary Oedema, Serum Ferritin Increased, Visual Acuity Reduced
Adverse event was reported on Sep 22, 2009 by a Male patient taking Desferal (View Usage) (Dosage: 3000 Mg/d) was diagnosed with haemosiderosis and. Location: SWITZERLAND , 70 years of age, After Desferal was administered, patient had the following side effects: cardiac discomfort, dyspnoea, incorrect dose administered, pulmonary oedema, serum ferritin increased, visual acuity reduced. During the same period patient was treated with EXJADE (1000 Mg/d) (View Exjade Review and Exjade Label ), CORDARONE (200 Mg/d) (View Cordarone Review and Cordarone Label ), GUTRON (5 Mg/d) (View Gutron Review and Gutron Label ).

6269960-0 | Blood Iron Increased, Ear Pain
on Jul 02, 2009 Male patient from SOUTH AFRICA , weighting 46.96 lb, was diagnosed with aplastic anaemia, iron overload and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: blood iron increased, ear pain. Desferal dosage: 1 Gm/day For 2 Consecutive Days Per Week. During the same period patient was treated with ASCORBIC ACID (50 Mg/day) (View Ascorbic Acid Review and Ascorbic Acid Label ).

6248326-3 | Liver Function Test Abnormal
on Jun 16, 2009 Female patient from GERMANY , 63 years of age, was diagnosed with haemosiderosis and was treated with Desferal (View Usage). Patient had the following side effects: liver function test abnormal. Desferal dosage: .

6248299-3 | Stem Cell Transplant
Patient was taking Desferal (View Usage). After Desferal was administered, patient had the following side effects: stem cell transplant on Jun 16, 2009 from GERMANY Additional patient health information: Female patient , child 10 years of age, weighting 61.73 lb, was diagnosed with haemosiderosis and. Desferal dosage: Unk.

6196232-5 | B-cell Lymphoma
Adverse event was reported on May 12, 2009 by a Female patient taking Desferal (View Usage) (Dosage: 4 Gm Five Days Per Week) was diagnosed with thalassaemia and. Location: UNITED STATES , weighting 130.1 lb, Patient experienced the following unwanted or unexpected effects: b-cell lymphoma. During the same period patient was treated with VITAMINS (1 Daily) (View Vitamins Review and Vitamins Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ), LEVOTHYROXINE SODIUM (0.75 Mcg Daily) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PREMARIN (0.625 Mg, Qd) (View Premarin Review and Premarin Label ). Patient was hospitalized and became disabled.

6194459-X | Injection Site Inflammation, Phlebitis
on May 08, 2009 Male patient from UNITED KINGDOM , weighting 158.7 lb, was diagnosed with iron overload and was treated with Desferal (View Usage). Patient had the following side effects: injection site inflammation, phlebitis. Desferal dosage: Unk.

6184589-0 | Application Site Bleeding, Serum Ferritin Increased
on Apr 30, 2009 Male patient from BRAZIL , 18 years of age, was diagnosed with congenital aplastic anaemia, deep brain stimulation and was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: application site bleeding, serum ferritin increased. Desferal dosage: 1500 Mg, Infusion For 8 Hrs At Night. During the same period patient was treated with METICORTEN (5 Mg Daily) (View Meticorten Review and Meticorten Label ), HEMOGENIN (25 Mg Daily) (View Hemogenin Review and Hemogenin Label ).

6134631-8 | Febrile Neutropenia, Hyperthermia, Infection, Pancytopenia, Renal Failure
Patient was taking Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, hyperthermia, infection (What is infection?), pancytopenia, renal failure on Mar 17, 2009 from JAPAN Additional patient health information: Female patient , 70 years of age, was diagnosed with iron overload, myelodysplastic syndrome and. Desferal dosage: 1000 Mg. During the same period patient was treated with THYRADIN S (100 Mg) (View Thyradin S Review and Thyradin S Label ), PRIMOBOLAN (20 Mg) (View Primobolan Review and Primobolan Label ), TAKEPRON (15 Mg) (View Takepron Review and Takepron Label ), AMINO ACIDS/CARBOHYDRATES/MINERALS/VITAMINS, (1000 Ml) (View Amino Acids/carbohydrates/minerals/vitamins, Review and Amino Acids/carbohydrates/minerals/vitamins, Label ), DECADRON (1 Mg) (View Decadron Review and Decadron Label ).

6129358-2 | Cardiac Failure, Febrile Neutropenia, Hepatic Failure, Hyperthermia, Pancytopenia, Renal Failure
Adverse event was reported on Mar 17, 2009 by a Female patient taking Desferal (View Usage) (Dosage: 1000 Mg) was diagnosed with iron overload, myelodysplastic syndrome and. Location: JAPAN , 70 years of age, Patient had the following side effects: cardiac failure, febrile neutropenia, hepatic failure, hyperthermia, pancytopenia, renal failure. During the same period patient was treated with EXJADE (Unk) (View Exjade Review and Exjade Label ), THYRADIN S (100 Mg) (View Thyradin S Review and Thyradin S Label ), PRIMOBOLAN (20 Mg) (View Primobolan Review and Primobolan Label ), TAKEPRON (15 Mg) (View Takepron Review and Takepron Label ), AMINO ACIDS/CARBOHYDRATES/MINERALS/VITAMINS, (1000 Ml) (View Amino Acids/carbohydrates/minerals/vitamins, Review and Amino Acids/carbohydrates/minerals/vitamins, Label ), DECADRON (1 Mg) (View Decadron Review and Decadron Label ). Patient was hospitalized.

6128928-5 | Application Site Bleeding, Serum Ferritin Increased
on Mar 11, 2009 Male patient from BRAZIL , 18 years of age, was diagnosed with congenital aplastic anaemia and was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: application site bleeding, serum ferritin increased. Desferal dosage: Infusion For 8 Hrs At Night. During the same period patient was treated with METICORTEN (View Meticorten Review and Meticorten Label ), HEMOGENIN (View Hemogenin Review and Hemogenin Label ).

6065258-4 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased
on Feb 03, 2009 Male patient from FRANCE , 67 years of age, was diagnosed with iron overload, refractory anaemia and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased. Desferal dosage: . During the same period patient was treated with RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ).

6055893-1 | Renal Injury
Patient was taking Desferal (View Usage). Patient had the following side effects: renal injury on Jan 19, 2009 from CANADA Additional patient health information: Male patient , 83 years of age, . Desferal dosage: .

6046608-1 | Bronchoalveolar Lavage, Bronchoscopy, Dyspnoea, Eosinophilic Pneumonia
Adverse event was reported on Jan 14, 2009 by a Male patient taking Desferal (View Usage) (Dosage: 2 G Daily) was diagnosed with iron overload and. Location: ITALY , 34 years of age, After Desferal was administered, patient had the following side effects: bronchoalveolar lavage, bronchoscopy, dyspnoea, eosinophilic pneumonia. During the same period patient was treated with FOSAMAX (70 Mg) (View Fosamax Review and Fosamax Label ).

6042056-9 | Asthenia, Bronchoalveolar Lavage, Bronchoscopy, Dyspnoea, Eosinophilic Pneumonia, Fatigue, Interstitial Lung Disease, Respiratory Disorder
on Dec 29, 2008 Male patient from ITALY , 34 years of age, was diagnosed with thalassaemia, iron overload and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, bronchoalveolar lavage, bronchoscopy, dyspnoea, eosinophilic pneumonia, fatigue, interstitial lung disease, respiratory disorder. Desferal dosage: 2 G Daily. During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ).

6026972-X | Bronchoalveolar Lavage, Bronchoscopy, Dyspnoea, Eosinophilic Pneumonia
on Dec 29, 2008 Male patient from ITALY , 34 years of age, was diagnosed with iron overload and was treated with Desferal (View Usage). Patient had the following side effects: bronchoalveolar lavage, bronchoscopy, dyspnoea, eosinophilic pneumonia. Desferal dosage: 2 G Daily. During the same period patient was treated with FOSAMAX (70 Mg) (View Fosamax Review and Fosamax Label ).

6021752-3 | Blood Creatinine Increased, Deafness, Progressive Multifocal Leukoencephalopathy, Pyrexia, Viral Infection
Patient was taking Desferal (View Usage). After Desferal was administered, patient had the following side effects: blood creatinine increased, deafness, progressive multifocal leukoencephalopathy, pyrexia, viral infection (What is viral infection?) on Dec 25, 2008 from JAPAN Additional patient health information: Male patient , 77 years of age, was diagnosed with serum ferritin and. Desferal dosage: 1000 Mg, Unk. During the same period patient was treated with NEORAL (View Neoral Review and Neoral Label ).

5943575-3 | Abdominal Pain Upper, Abdominal Wall Haemorrhage, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Amylase Increased, Blood Bilirubin Increased, Blood Creatinine Increased, Blood Glucose Increased
Adverse event was reported on Nov 04, 2008 by a Male patient taking Desferal (View Usage) (Dosage: 1000 Mg/day) was diagnosed with iron overload, haemosiderosis, gastric ulcer, liver disorder, hypothyroidism, bacterial infection (What is bacterial infection?), graft versus host disease and. Location: JAPAN , 61 years of age, weighting 85.98 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, abdominal wall haemorrhage, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood amylase increased, blood bilirubin increased, blood creatinine increased, blood glucose increased. During the same period patient was treated with FAMOTIDINE (20 Mg) (View Famotidine Review and Famotidine Label ), GLYCERON TAB (6 Df) (View Glyceron Tab Review and Glyceron Tab Label ), URSO 250 (600 Mg) (View Urso 250 Review and Urso 250 Label ), LEVOTHYROXINE SODIUM (25 Mg) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CRAVIT (300 Mg) (View Cravit Review and Cravit Label ), DIFLUCAN (200 Mg) (View Diflucan Review and Diflucan Label ), PREDONINE (10 Mg) (View Predonine Review and Predonine Label ).

5936097-7 | B-cell Lymphoma
on Oct 24, 2008 Female patient from UNITED STATES , weighting 130.1 lb, was diagnosed with thalassaemia and was treated with Desferal (View Usage). Patient had the following side effects: b-cell lymphoma. Desferal dosage: 4 Gm Five Days Per Week. During the same period patient was treated with VITAMINS (1 Daily) (View Vitamins Review and Vitamins Label ), FOLIC ACID (1 Mg, Qd) (View Folic Acid Review and Folic Acid Label ), LEVOTHYROXINE SODIUM (0.75 Mcg Daily) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PREMARIN (0.625 Mg, Qd) (View Premarin Review and Premarin Label ). Patient was hospitalized and became disabled.

5934376-0 | Blood Creatinine Increased, Deafness, Pyrexia
on Oct 23, 2008 Male patient from JAPAN , 77 years of age, was diagnosed with serum ferritin and was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: blood creatinine increased, deafness, pyrexia. Desferal dosage: 1000 Mg, Unk. During the same period patient was treated with NEORAL (View Neoral Review and Neoral Label ).

5922551-0 | Hepatitis Infectious, Nuclear Magnetic Resonance Imaging Abnormal, Transaminases Abnormal
Patient was taking Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis infectious, nuclear magnetic resonance imaging abnormal, transaminases abnormal on Oct 09, 2008 from BRAZIL Additional patient health information: Male patient , 16 years of age, weighting 87.08 lb, was diagnosed with thalassaemia beta and. Desferal dosage: 5 Flasks/day. During the same period patient was treated with FERRIPROX (7 Tabs A Day) (View Ferriprox Review and Ferriprox Label ). Patient was hospitalized.

5914879-5 | Hypophagia, Injection Site Pain, Injection Site Swelling, Malaise, Mobility Decreased, Nausea, Serum Ferritin Increased
Adverse event was reported on Oct 02, 2008 by a Male patient taking Desferal (View Usage) (Dosage: 1 Df, Unk) was diagnosed with serum ferritin increased, thalassaemia beta, pain (What is pain?), nausea (What is nausea?) and. Location: BRAZIL , 69 years of age, weighting 180.8 lb, Patient had the following side effects: hypophagia, injection site pain, injection site swelling, malaise, mobility decreased, nausea (What is nausea?), serum ferritin increased. During the same period patient was treated with FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PLASIL (Unk) (View Plasil Review and Plasil Label ), ORAL ANTIDIABETICS (View Oral Antidiabetics Review and Oral Antidiabetics Label ).

5869938-2 | Abdominal Pain Upper, Abdominal Wall Haemorrhage, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Amylase Increased, Blood Bilirubin Increased, Blood Creatinine Increased, Blood Glucose Increased
on Aug 28, 2008 Male patient from JAPAN , 56 years of age, weighting 85.98 lb, was diagnosed with iron overload, haemosiderosis, gastric ulcer, liver disorder, hypothyroidism, bacterial infection (What is bacterial infection?), graft versus host disease and was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: abdominal pain upper, abdominal wall haemorrhage, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood amylase increased, blood bilirubin increased, blood creatinine increased, blood glucose increased. Desferal dosage: 1000 Mg/day. During the same period patient was treated with FAMOTIDINE (20 Mg) (View Famotidine Review and Famotidine Label ), GLYCERON TAB (6 Df) (View Glyceron Tab Review and Glyceron Tab Label ), URSO 250 (600 Mg) (View Urso 250 Review and Urso 250 Label ), LEVOTHYROXINE SODIUM (25 Mg) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CRAVIT (300 Mg) (View Cravit Review and Cravit Label ), DIFLUCAN (200 Mg) (View Diflucan Review and Diflucan Label ), PREDONINE (10 Mg) (View Predonine Review and Predonine Label ).

5863377-6 | Back Pain, Blood Creatinine Increased, Bronchoscopy Abnormal, Chest Pain, Computerised Tomogram Abnormal, Dehydration, Dizziness, Dyspnoea
on Aug 20, 2008 Female patient from UNITED STATES , weighting 105.2 lb, was diagnosed with iron overload and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), blood creatinine increased, bronchoscopy abnormal, chest pain (What is chest pain?), computerised tomogram abnormal, dehydration, dizziness (What is dizziness?), dyspnoea. Desferal dosage: 9000 Mg, Qd. During the same period patient was treated with DEFERIPRONE (3500 Mg Daily Divided Tid) (View Deferiprone Review and Deferiprone Label ), TYLENOL W/ CODEINE (! Tab Every 4-6 Hours As Needed) (View Tylenol W/ Codeine Review and Tylenol W/ Codeine Label ), CALCIUM CARBONATE (2 Ml Po Bid) (View Calcium Carbonate Review and Calcium Carbonate Label ), DIGOXIN (0.25 Mg Daily) (View Digoxin Review and Digoxin Label ), ORTHO TRI CYCLEN (1 Tablet Daily) (View Ortho Tri-cyclen Review and Ortho Tri-cyclen Label ), L CARNITINE (2 Capsules 4 Times A Day) (View L-carnitine Review and L-carnitine Label ), ZOFRAN (8 Mg Q 6h Prn) (View Zofran Review and Zofran Label ), ZANTAC (150 Mg Bid) (View Zantac Review and Zantac Label ). Patient was hospitalized.

5850239-3 | Myodesopsia
Patient was taking Desferal (View Usage). Patient had the following side effects: myodesopsia on Aug 11, 2008 from JAPAN Additional patient health information: Female patient , 58 years of age, was diagnosed with serum ferritin increased and. Desferal dosage: 500 Mg/day.

5838411-X | Deafness, Femur Fracture, Leukocytosis
Adverse event was reported on Jul 29, 2008 by a Female patient taking Desferal (View Usage) (Dosage: 1 Injection Every 25 Days) was diagnosed with iron overload and. Location: FRANCE , 74 years of age, After Desferal was administered, patient had the following side effects: deafness, femur fracture, leukocytosis. During the same period patient was treated with FRAXIPARINE (View Fraxiparine Review and Fraxiparine Label ).

5817723-X | Myodesopsia
on Jul 15, 2008 Female patient from JAPAN , 58 years of age, was diagnosed with serum ferritin increased and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: myodesopsia. Desferal dosage: 500 Mg/day.

5815991-1 | Hepatitis Infectious, Nuclear Magnetic Resonance Imaging Abnormal, Transaminases Abnormal
on Jul 10, 2008 Male patient from BRAZIL , 16 years of age, weighting 87.08 lb, was diagnosed with thalassaemia beta and was treated with Desferal (View Usage). Patient had the following side effects: hepatitis infectious, nuclear magnetic resonance imaging abnormal, transaminases abnormal. Desferal dosage: 5 Flasks/day. During the same period patient was treated with FERRIPROX (7 Tabs A Day) (View Ferriprox Review and Ferriprox Label ). Patient was hospitalized.

5746330-2 | Nausea
Patient was taking Desferal (View Usage). After Desferal was administered, patient had the following side effects: nausea (What is nausea?) on May 09, 2008 from UNITED STATES Additional patient health information: Female patient , 26 years of age, weighting 124.3 lb, was diagnosed with blood iron increased, sickle cell anaemia, asthma (What is asthma?) and. Desferal dosage: 1125 Mg, Qd. During the same period patient was treated with METHADONE HYDROCHLORIDE (View Methadone Hydrochloride Review and Methadone Hydrochloride Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), BENADRYL (View Benadryl Review and Benadryl Label ), TYLENOL (View Tylenol Review and Tylenol Label ), CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ), LACTULOSE (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

5740067-1 | Nausea, Sickle Cell Anaemia With Crisis
Adverse event was reported on May 09, 2008 by a Female patient taking Desferal (View Usage) (Dosage: 1125 Mg, Qd) was diagnosed with blood iron increased, sickle cell anaemia, asthma (What is asthma?) and. Location: UNITED STATES , 26 years of age, weighting 124.3 lb, Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?), sickle cell anaemia with crisis. During the same period patient was treated with METHADONE HYDROCHLORIDE (View Methadone Hydrochloride Review and Methadone Hydrochloride Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), BENADRYL (View Benadryl Review and Benadryl Label ), TYLENOL (View Tylenol Review and Tylenol Label ), CLINDAMYCIN HCL (View Clindamycin Hcl Review and Clindamycin Hcl Label ), LACTULOSE (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

5738625-3 | Transfusion-related Acute Lung Injury
on May 07, 2008 Female patient from BRAZIL , 24 years of age, weighting 147.7 lb, was diagnosed with ceruloplasmin decreased and was treated with Desferal (View Usage). Patient had the following side effects: transfusion-related acute lung injury. Desferal dosage: Unk, Qw2. During the same period patient was treated with PLASMA (600 Ml, Unk) (View Plasma Review and Plasma Label ), SODIUM CHLORIDE (250 Ml, Unk) (View Sodium Chloride Review and Sodium Chloride Label ).

5726647-8 | Portal Hypertension, Portal Vein Thrombosis, Varices Oesophageal
on Apr 24, 2008 Female patient from ITALY , 38 years of age, weighting 125.7 lb, was diagnosed with haemosiderosis, amenorrhoea and was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: portal hypertension, portal vein thrombosis, varices oesophageal. Desferal dosage: 10 Mg/kg, Qd. During the same period patient was treated with SANDRENA (View Sandrena Review and Sandrena Label ), FARLUTAL (View Farlutal Review and Farlutal Label ).

5710933-1 | Portal Hypertension, Portal Vein Thrombosis, Varices Oesophageal
Patient was taking Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: portal hypertension, portal vein thrombosis, varices oesophageal on Apr 10, 2008 from ITALY Additional patient health information: Female patient , 38 years of age, weighting 125.7 lb, was diagnosed with haemosiderosis and. Desferal dosage: 10 Mg/kg, Qd.

5706026-X | Blood Creatinine Increased, Renal Failure
Adverse event was reported on Apr 06, 2008 by a Female patient taking Desferal (View Usage) (Dosage: 2 Mg, Qw5) was diagnosed with thalassaemia beta and. Location: ISRAEL , 58 years of age, weighting 127.9 lb, Patient had the following side effects: blood creatinine increased, renal failure.

5703684-0 | Retinal Haemorrhage
on Apr 01, 2008 Male patient from UNITED KINGDOM , 67 years of age, was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: retinal haemorrhage. Desferal dosage: Unk, Unk.

5699664-4 | Retinal Haemorrhage
on Apr 01, 2008 Male patient from UNITED KINGDOM , 67 years of age, was diagnosed with hypertriglyceridaemia and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: retinal haemorrhage. Desferal dosage: 75 Mg/day.

5670534-0 | Acute Respiratory Distress Syndrome, Blood Creatinine Increased, Mechanical Ventilation, Oxygen Saturation Decreased, Renal Failure
Patient was taking Desferal (View Usage). Patient had the following side effects: acute respiratory distress syndrome, blood creatinine increased, mechanical ventilation, oxygen saturation decreased, renal failure on Mar 13, 2008 from GERMANY Additional patient health information: Female patient , 61 years of age, was diagnosed with haemosiderosis and. Desferal dosage: . During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), KATADOLON (View Katadolon Review and Katadolon Label ). Patient was hospitalized.